Peritoneal dissemination complicating morcellation of uterine mesenchymal neoplasms

Michael A Seidman1, Titilope Oduyebo, Michael G Muto

  • 1Division of Women's and Perinatal Pathology, Department of Pathology, Brigham & Women's Hospital/Harvard Medical School, Boston, Massachussetts, United States of America. mseidman@partners.org

Plos One
|November 29, 2012
PubMed
Abstract

Insights

Power morcellation for uterine fibroids risks spreading unexpected cancers. Disseminated leiomyosarcoma after morcellation is linked to increased mortality, a risk higher than currently disclosed.

Area of Science:

  • Gynecologic Oncology
  • Minimally Invasive Surgery
  • Pathology

Background:

  • Power morcellation is a common technique for uterine leiomyoma resection.
  • The procedure can lead to the dissemination of cellular material within the peritoneum.
  • Unexpected findings of leiomyosarcoma or other malignant/atypical tumors can have serious clinical consequences.

Purpose of the Study:

  • To determine the frequency of intraperitoneal dissemination of unexpected neoplasms after uterine morcellation.
  • To assess the clinical consequences of such dissemination.

Main Methods:

  • Retrospective review of 1091 uterine morcellation cases from 2005-2010.
  • Analysis of follow-up laparoscopies for disseminated disease.
  • Pathologic evaluation of morcellation and follow-up specimens.

Main Results:

  • 1.2% of cases revealed unexpected leiomyoma variants or malignant smooth muscle tumors.
  • The rate of unexpected sarcoma was 0.09%, significantly higher than patient briefings.
  • Disseminated disease occurred in 64.3% of all unexpected tumors, with leiomyosarcoma associated with mortality.

Conclusions:

  • Uterine morcellation carries a risk of disseminating unexpected malignancies.
  • The risk of dissemination and associated mortality appears higher than currently recognized.
  • Proposed procedures for pathologic evaluation and follow-up are suggested.